Search for: "Endo Pharmaceutical Solutions"
Results 21 - 40
of 42
Sort by Relevance
|
Sort by Date
9 Jun 2014, 11:25 am
Last month, as reported by the Los Angeles Times, the California counties of Orange and Santa Clara sued Actavis, Endo Health Solutions Inc., Johnson & Johnson's Janssen Pharmaceuticals, Purdue Pharma and Teva Pharmaceutical Industries' Cephalon Inc. for causing the national prescription drug epidemic. [read post]
15 Apr 2014, 6:21 am
Endo Health Solutions Inc. [read post]
6 Mar 2014, 3:25 pm
Endo Health Solutions Inc. anticipates it will cost at least $520 million to settle or otherwise exit the vaginal mesh product liability litigation it now faces. [read post]
28 Feb 2014, 8:09 am
Endo Pharmaceuticals Pays Settlement for Off-Label Marketing of Lidoderm Pain Patch Endo Health Solutions Inc and its subsidiary Endo Pharmaceuticals have agreed to pay $171.9 million to settle False Claims allegations for off-label marketing of their pain patch, Lidoderm. [read post]
26 Feb 2014, 11:18 am
The post Endo Health Solutions & Endo Pharmaceuticals to Pay $192.7 Million in Qui Tam Case Alleging Off-Label Marketing Of Lidoderm Pain Treatment Patches appeared first on Tycko & Zavareei LLP. [read post]
24 Feb 2014, 8:37 am
According to DOJ’s press release: Pharmaceutical company Endo Health Solutions Inc. and its subsidiary Endo Pharmaceuticals Inc. [read post]
21 Feb 2014, 10:20 am
The settlements are listed below: Endo Pharmaceuticals and Endo Health Solutions to Pay $192.7 Million to Resolve Criminal and Civil Liability Relating to Marketing of Prescription Drug Lidoderm for Unapproved Uses Pharmaceutical company Endo Health Solutions Inc. and its subsidiary Endo Pharmaceuticals Inc. [read post]
9 Aug 2012, 5:00 am
Nittany Pharmaceuticals (?) [read post]
3 May 2012, 6:07 pm
In 2009, Allergan and its business partners, Endo Pharmaceutical Solutions and Supernus Pharmaceuticals, filed their complaint in Delaware that Watson and its business partners, Florida, Sandoz and Paddock Laboratories, had infringed on Allergan patents involving trospium chloride extended release capsules to treat the symptoms of overactive bladders in humans. [read post]
2 Mar 2012, 6:52 am
(bowel preparation solution) Deposition2007-07-10 Pryor v. [read post]
2 Feb 2012, 8:53 pm
Ethicon Endo (surgical stapler) Trial2010-06-04 Phillipi v. [read post]
15 Sep 2011, 1:00 pm
Johnson & Johnson and Endo Pharmaceuticals Holdings- More safety studies and labeling changes could help. [read post]
29 Jun 2011, 9:00 am
Qualitest is a wholly owned subsidiary of Endo Pharmaceuticals (Nasdaq: ENDP), a U.S. [read post]
17 May 2011, 10:37 pm
Endo Pharmaceuticals appealed three applications related to time-released opioids. [read post]
4 May 2011, 7:52 am
Generic Opioid Products Generic Name Drug Name Applicant/Sponsors Fentanyl Fentanyl Extended Release Transdermal System Actavis Fentanyl Fentanyl Extended Release Transdermal System Lavipharm Labs Fentanyl Fentanyl Extended Release Transdermal System Mylan Technologies Fentanyl Fentanyl Extended Release Transdermal System Teva Pharms Fentanyl Fentanyl Extended Release Transdermal System Watson Methadone … [read post]
13 Jun 2010, 9:35 pm
.; Allergan Sales LLC; Endo Pharmaceuticals Solutions Inc.; Supernus Pharmaceuticals Inc. [read post]
27 Apr 2010, 10:58 pm
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://thinkipstrategy.com/subscribe/ Highlights this week included: Kenya High Court suspends Anti-Counterfeiting Act ‘in as far as it applies to generic medicines’ (Afro-IP) (Michael Geist) India: Roche and Tarceva in Delhi HC again, this time vs Natco (Spicy IP) (Generic Pharmaceuticals and IP) Ecuador: Compulsory license granted to Cipla for Lopinavir + Ritonavir (Generic… [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
10 Feb 2010, 4:47 pm
Mylan Pharmaceuticals Inc. [read post]
